AITNMC Checklist serial no, 18b

Complete MBBS Phase II Schedule, Government Medical College, Amritsar 2023 (September 2024 onwards)
07:30 - 08:30 AM 08:30 - 09:30 AM 09:30 - 11:30 AM 11:30 AM- 12:30- 01:30 01:30 - 02:30 PM 02:30 - 03:30 PM
Small group learning 12:30 PM PM
(Tutorials/Seminars/Integrated
Learning/SDL/ Practical/SGD)

Monday AETCOM Pathology Pathology - A SPM SPM SPM SPORTS

Pharmacology - B L/SGD/SDL L/SGD/SDL (L/SGD/SDL)
Microbiology -C

Tuesday Forensic Pharmacology Pathology Pathology B Clinical posting / Practical [ Pathology/Pharmacology - Small group
Medicine Pharmacology C learning (Tutorials/Seminars/Integrated Learning/Practical/SGD) ]
Microbiology A Break
Wednesday Medicine Microbiology Pharmacology Pathology C

Pharmacology A
Microbiology B
Thursday Surgery Pathology Pharmacology Pathology A
Pharmacology B
Microbiology C
Friday Obs. & Pathology Microbiology Pathology B
Gynaecology Pharmacology C
Microbiology A
Saturday Pharmacology Forensic Medicine Microbiology Pathology C

Pharmacology A

Microbiology B

SGD- Small Group Discussion SDL- Self Directed Learning

Batch A- Roll No 1-85, Batch B- Roll No 86-170, Batch C- Roll No171-250
PART COMPLETION TEST- 1 from 25-11-2024 to 07-12-2024
PART COMPLETION TEST- 2 from 17-03-2025 to 28-03-2025
Summer holidays from 14-07-2025 to 20-07-2025
Pre-University examination from 21-07-2025 onwards
Winter holidays from 30-12-2024 to 04-01-2025
Remaining classes of sports will be taken in evening from 5:00 pm to 6:00 pm on Mondays
Colour Code Legend
Pharmacology Pandemic Module Medicine
Microbiology AETCOM Obstetrics & Gynaecology
Pathology Clinical postings Surgery
Forensic Medicine AITOCo-ordination Break
SPM Sports Day & Extracurricular Activities Holiday
Internal Assessment Send up Feedback session
Week 1 07:30 - 08:30 AM 08:30 - 09:30 AM 09:30 - 11:30 AM 11:30 AM- 12:30 - 01:30 01:30 - 02:30 PM 02:30 - 03:30 PM
12:30 PM PM

Monday AETCOM -L L1 1 A SGD1 PA8.1,8.2 Cytology FAP Field visit I

02-09-2024 Module 2.1 Foundations of PA 1.1, 1.2,1.3
B SGD (1) PH 1.9
communication Role of pathologist
Drug Nomenclature
Break
C SGD (1) MI 1.1
History & bact. Taxonomy
Tuesday L1 L2 1 B SGD1PA8.1,8.2 Cytology Clinical Posting
PA 2.1, 2.2
03-09-2024 FM 1.1, 1.3,1.4,1.5& 1.6. Basics Cell Injury
of Forensic Medicine, Legal C SGD (1) PH 1.9
procedures, Courts in India, Drug Nomenclature
Court procedure, offenses in A SGD (1) MI 1.1
History & bact. Taxonomy
Court,Perjury
Wednesday L1 L1 1 C SGD1 PA8.1,8.2 Cytology
04-09-2024 IM4.3 common PH 1.1
causes,pathophysiology and Principles of A SGD (1) PH 1.9
manifestations of fever in various Drug Nomenclature
Pharmacology
regions in India including B SGD (1)MI 1.1
bacterial,parasitic and viral causes History & bact. Taxonomy
Intg:microbiology and community
medicine
Thursday L1 L2 2 A DOAP 1 PA8.3 Cytology Staining
05-09-2024
SU1.1 PH 1.1
Metabolic response to injury and Routes of Drug B SGD (2) PH 1.3
its mediators Admin. Drug Formulations
CSGD (2) MI 1.1, 8.6
Std. safety precautions
Friday L1 L1 2 B DOAP 1 PA8.3 Cytology Staining
06-09-2024 OG 2.1
MI1.1.1
Anatomy of internal organs of Introduction to C SGD (2) PH 1.3
female reproductive system Drug Formulations
Microbiology
A SGD (2) MI 1.1, 8.6
Std. safety precautions
Saturday L2 L2 2 C DOAP 1 PA8.3 Cytology Staining
07-09-2024
FM 2.1, 2.2, 2.3 , 2.5, 2.6, 2.7 MI 1.1
Discuss death, natural and Morphology of A SGD (2) PH 1.3
unnatural deaths, modes of Bacteria Drug Formulations
death, Suspended animation, B SGD (2) MI 1.1, 8.6
Std. safety precautions
Presumption of death and
survivorship
Week 2 07:30 - 08:30 AM 08:30 - 09:30 AM 09:30 - 11:30 AM 11:30 AM- 12:30 - 01:30 - 02:30 02:30 -
12:30 PM 01:30 PM 03:30 PM
PM

Monday AETCOM –FSGD L3 3 A DOAP 2 PA2.8 Cell Injury (Fatty change) L1 L2 SDL1a
09-09-2024 Foundation of communication 2 PA2.3,3.1
Accumulations.
CM 5.1 CM 5.3 CM 3.1
Amyloidosis B DOAP (1) PH 2.1 NUTRITION Common Air
Parenteral Route Vitamin Pollution
C SGD (3) MI 1.1 deficiencies
Microscopy
and related
Break disorders
Tuesday SGL 1 L4 3 B DOAP 2 PA2.8 Cell Injury (Fatty change) Clinical Posting
10-09-2024 PA2.4
FM 1.7 &1.8 Necrosis & Apoptosis
C DOAP (1) PH 2.1
Latest court advances, Dying Declaration Parenteral Route
& Dying Deposition A SGD (3) MI 1.1
Microscopy
Wednesday L2 L3 3 C DOAP 2 PA2.8 Cell Injury (Fatty change)
11-09-2024
IM4.3 common causes,pathophysiology PH 1.4
and manifestations of fever in various Absorption A DOAP (1) PH 2.1
regions in India including Parenteral Route
bacterial,parasitic and viral causes B SGD (3) MI 1.1
Microscopy
Intg:microbiology and community
medicine
Thursday L2 L4 4 A DOAP 3 PA3.2 Amyloidosis
12-09-2024
SU 1.2 PH 1.4
Topic: Metabolic response to injury Distribution B DOAP (2) PH 4.1
(factors that affect metabolic response to Inhalational Route
injury) C (Pandemic Module 1) PM 2.3
Sample Collection

Friday L2 L3 4 B DOAP 3 PA3.2 Amyloidosis

13-09-2024 OG2.1.
MI 1.1Physiology of
Anatomy of external female pelvic Bacteria C DOAP (2) PH 4.1
organs and perineum Inhalational Route
A (Pandemic Module 1) PM 2.3
Sample Collection
Saturday SGL 2 L4 4C DOAP 3 PA3.2 Amyloidosis
14-09-2024
FM 1.10, 1.11 MI 1.4,1.5
Cause of death by referring ICD 10 code, Methods of Sterilization A DOAP (2) PH 4.1
Death certificate Inhalational Route
B (Pandemic Module 1) PM 2.3
Sample Collection
 07:30 - 08:30 AM 08:30 - 09:30 AM 09:30 - 11:30 AM 11:30 AM- 12:30 - 01:30 - 02:30 02:30 -
Week 3 12:30 PM 01:30 PM 03:30 PM
PM

Monday AETCOM 2.1 FSGD L5 5 A DOAP3 2.8 Calcification PANDEMIC Module 2.2 Emerging and
16-09-2024 Foundation of communication 2 PA2.5,2.6,2.7 Re-emerging
Calcification, Adaptations,
B DOAP (3) PH 1.9 Break infections, early identification and
Cellular aging
Intravenous Drip control of new infections (SPM)
C SGD (4)MI 1.4, 1.5
App. of sterilization Clinical Posting
Tuesday L3 FM 2.9 L6 5 B DOAP3 2.8 Calcification
17-09-2024 PA4.1
Putrefaction, mummification, adipocere General Features of
and maceration Inflammation C DOAP (3) PH 1.9
Intravenous Drip
A SGD (4) MI 1.4, 1.5
App. of sterlization
Wednesday L3 5 C DOAP3 2.8 Calcification
18-09-2024
IM4.4 pathophysiology and L5 A DOAP (3) PH 1.9
manifestations of inflammatory causes of PH 1.4 Intravenous Drip
fever Intg: microbiology Drug Metabolism B SGD (4)MI 1.4, 1.5
App. of sterlization
Thursday L3 L6 6 A DOAP 4 PA4.4 Acute Inflammation
19-09-2024
SU 1.3 PH 1.4
Metabolic response to injury (basic Excretion-1 B DOAP (4) PH 1.9
concept of perioperative care) Intravenous Drip (Revision)
C (Pandemic Module 2) PM 2.1
Infection control &MI1.4,1.5 disinfect.
Mi 8.5, 8.6, 8.7 HAI (Seminar 1)
Friday L3. L5 6 B DOAP 4 PA4.4 Acute Inflammation
OG2.1
20-09-2024 MI 1.4, 1.5
Blood supply, nerve supply, lymphatic C DOAP (4) PH 1.9
Methods of Disinfection
drainage and Relation of female Intravenous Drip (Revision)
reproductive tract with other pelvic A (Pandemic Module 2) PM 2.1
organs and connective tissue Infection control &MI1.4,1.5 disinfect.
Mi 8.5, 8.6, 8.7 HAI (Seminar 1)
Saturday L4 L6 6 C DOAP 4 PA4.4 Acute Inflammation
21-09-2024
FM 2.25 Burns scalds, lightening, MI 1.1
electrocution and radiations Bacterial genetics A DOAP (4) PH 1.9
Intravenous Drip
(Revision)
B (Pandemic Module 2) PM 2.1
Infection control &MI1.4,1.5disinfect.
Mi 8.5, 8.6, 8.7 HAI (Seminar 1)
Week 4 07:30 - 08:30 AM 08:30 - 09:30 AM 09:30 - 11:30 AM 11:30 12:30 - 01:30 01:30 - 02:30 PM 02:30 - 03:30 PM
AM- PM
12:30
PM
Monday 4 AETCOM -4 L7 7 A DOAP 4 PA4.4 Chronic Inflammation PANDEMIC Module 2.2 Emerging and Re-emerging
23-09-2024 Module 2.1 PA4.2 infections, early identification and
Mediators of Inflammation
Discussion and closure B SGD (3) PH 1.52 control of new infections
Common Poisoning 1 (SPM)
C DOAP (1) MI 1.2
Gram Staining 1
Tuesday L5 7 B DOAP 4 PA4.4 Chronic Inflammation Clinical Posting
Break
24-09-2024 L8
FM 2.22 Mechanical asphyxia
PA4.3 C SGD (3) PH 1.52
Chronic Inflammation
Common Poisoning 1
A DOAP (1)MI 1.2
Gram Staining 1
Wednesday L4 L7 7 C DOAP 4 PA4.4 Chronic Inflammation
25-09-2024
IM4.8 pathophysiology, aetiology PH 1.4
and clinical manifestations of fever Excretion-2 A SGD (3) PH 1.52
of unknown origin (FUO) Intg: Common Poisoning 1
microbiology B DOAP (1) MI 1.2
Gram Staining 1
Thursday L4 L8 8 A SGD 4PA10.1 Malaria
26-09-2024
SU 2.1 PH 1.5
SHOCK Describe Pathophysiology Pharmacodynamics- B SGD (4) PH 1.52
of shock (types , principles of 1 Common Poisoning 2
resuscitation ,fluid replacement C SGD (5) MI 1.1
Culture Media
and monitoring)
Friday L4. L7 8 B SGD 4PA10.1 Malaria
27-09-2024 OG 3.1
MI 1.6
Physiology of menstrual cycle 1 C SGD (4) PH 1.52
Antimicrobial agents
& Resistance Common Poisoning 2
A SGD (5)MI 1.1
Culture Media
Saturday L6 L8 8 C SGD 4PA10.1 Malaria
28-09-2024
FM 3.7 , 2.23 Injuries and healing, MI 1.6
medicolegal aspects of drowning, AST & Antimicrobial A SGD (4) PH 1.52
diatom test and gettler test. stewardship Common Poisoning 2
B SGD (5) MI 1.1
Culture Media
Week 5 07:30 - 08:30 AM 08:30 - 09:30 AM 09:30 - 11:30 AM 11:30 AM- 12:30 - 01:30 01:30 - 02:30 PM 02:30 - 03:30 PM
12:30 PM PM
Monday AETCOM Module 2.2 L9 9 A SGD 6PA10.3 Leprosy BREAK FAP Field Visit II
30-09-2024 Foundation of Bioethics PA6.1
LGD Edema
B SGD (5) PH 2.4
Drugs in pregnancy
C SGD (6)MI 1.1
Culture Methods
Tuesday L7 L10 9 B SGD 6PA10.3 Leprosy
01-10-2024 PA6.2,6.3
FM 3.1 Identification Part Congestion,
1 Shock C SGD (5) PH 2.4
Drugs in pregnancy
A SGD (6) MI 1.1
Culture Methods

Wednesday HOLIDAY
02-10-2024
Thursday HOLIDAY
03-10-2024

Friday L5 L9 10 B SGD 6PA10.3 Leprosy (Revision)

04-10-2024 OG 3.1
MI 1.1
Physiology of menstrual CSGD (6) PH 1.56
Overview of Bacterial
cycle 2 Drugs in pediatrics
infections
A SGD (7) MI1.3
Epidemiology of Infect. ds
Saturday L8 L10 9 C SGD 6PA10.3 Leprosy
05-10-2024
FM 3.2 Identification Part MI 1.1
2 Overview of Viral Infections A SGD (5) PH 2.4
Drugs in pregnancy
B SGD (7)MI1.3
Epidemiology of Infect. ds

Week 6 07:30 - 08:30 AM 08:30 - 09:30 AM 09:30 - 11:30 AM 11:30 12:30 - 01:30 01:30 - 02:30 - 03:30
AM- PM 02:30 PM PM
12:30
PM
Monday AETCOM Module 2.2 Foundation of L11 10 A SGD 5PA10.2 Break L3 L4 SDL 1b
Bioethics Large group discussion PA6.4,6.5 Cystecercosis
07-10- Thrombosis,
CM 5.3 CM 5.3 CM 3.1
2024 Embolism B SGD (6) PH 1.56 Zinc, Iodine,Flourine,Iron Protein Energy Air Pollution
Drugs in deficiency Disorders Malnutrition Subission
paediatrics
C SGD (8)MI 1.1
Bacterial
identification-I
Tuesday SGD 3 L12 11 B SGD 5PA10.2
08-10-2024 PA7.1 Cystecercosis
FM 2.4 Organ Transplantaion Neoplasia
C SGD (7) PH 1.56 Clinical posting
Drugs in Geriatrics
A SGD (8) MI 1.1
Bacterial
identification-I
Wednesday L5 L9 10 C SGD
09-10-2024 5PA10.2
IM17.3 Classify Migraine and describe the PH 1.5
Cystecercosis
distinguishing features b/w classical and Pharmacodynamics-
non-classical migraine 2 ASGD (6) PH 1.56
Drugs in pediatrics
B SGD (8)MI 1.1
Bacterial
identification-I
Thursday L5 L10 11 A SGD 7PA10.4
10-10-2024 Infectious Disease
SU 5.1 PH 1.13
Wound healing and wound care Intro ANS & B SGD (7) PH 1.56
Adrenergic drugs Drugs in Geriatrics
C SGD (9)MI 1.1
Bacterial identification-
II
Friday L6 L11 12 B SGD 7PA10.4
11-10-2024 OG 3.1 Infectious Disease
MI 1.1
Physiology of reproduction: C SGD (8) PH 1.12
Overview of Fungal
gametogenesis, fertilisation and Drugs in Renal ds.
infections
implantation
A SGD (9) MI 1.1
Bacterial identification-
II
Saturday
12-10-2024
Week 7 07:30 - 08:30 AM 08:30 - 09:30 AM 09:30 - 11:30 AM 11:30 AM- 12:30 12:30 - 01:30 01:30 - 02:30 PM 02:30 - 03:30 PM
PM PM

Monday AETCOM 2.3 Health care as L13 12 A SGD 8PA6.6 PANDEMIC Module 2.4 Vaccination strategies
14-10-2024 right Seminar PA7.2 Ischemia/Infarction including
Molecular vaccine development &
Cancer B SGD (8) PH 1.12
Implementation (SPM)
Drugs in Renal ds.
C SGD (10)MI 1.1
Molecular Methods
Tuesday L9 L14 13 B SGD 8PA6.6 Ischemia/Infarction Break Clinical Posting
15-10-2024 PA7.3
FM 3.5, 3.6 Carcinogenesis
Mechanical injuries Part 1 C SGD (9) PH 1.7
Adverse Drug Reactions
A SGD (10)MI 1.1
Molecular Methods
Wednesday L6 L11 11 C SGD 7PA10.4 Infectious Disease
16-10-2024
IM16.3 Describe and discuss PH 1.13
the chronic effects of Anti-Adrenergic Drugs 2 A SGD (7) PH 1.56
diarrhoea including Drugs in Geriatrics
malabsorption B SGD (10)MI 1.1
Molecular Methods
Thursday HOLIDAY
17-10-2024

Friday L7 L12 14B SGD 8PA6.6 Ischemia/Infarction

18-10-2024 OG 4.1
Placenta formation and MI 1.7 C SGD (10) PH 1.6
structure Immunity & PvPI
immunological mech. A SGD (11)MI 8.5,8.6
BMW Management
in health
Saturday SGD 4 L13 12 C SGD 8PA6.6 Ischemia/Infarction
19-10-2024 MI 1.7
FM2.24 A SGD (8) PH 1.12
Thermal deaths. Antigen & Antibodies Drugs in Renal ds.
B SGD (11)MI 8.5,8.6
BMW Management
Week 8 07:30 - 08:30 AM 08:30 - 09:30 AM 09:30 - 11:30 AM 11:30 AM- 12:30 12:30 - 01:30 01:30 - 02:30 PM 02:30 - 03:30 PM
PM PM

Monday AETCOM 2.3 Health care as right L15 13 A DOAP 5 PA6.7 Infarct Specimen. PANDEMIC Module 2.4 Vaccination strategies
21-10-2024 Seminar PA7.5 Break including
Immunology of vaccine development &
Cancer B SGD (9) PH 1.7
Adverse Drug Reactions Implementation (Biochem)
C DOAP (2)MI 8.5, 8.6
Hand Hygiene& PPE-1
Tuesday SGD 5 L16 15 B DOAP 5 PA6.7 Infarct Specimen. Clinical posting
22-10-2024 PA9.1
FM 2.26 Principles of C SGD (11) PH 1.6
Starvation and neglect Immunity PvPI (Revision)
A DOAP (2)MI 8.5, 8.6
Hand Hygiene& PPE-1
Wednesday L12 13 C DOAP 5 PA6.7 Infarct Specimen.
23-10-2024
L7 IM9.18 Describe the PH 1.14
Cholinergic Drugs A SGD (9) PH 1.7
precautions required Adverse Drug Reactions
necessary when B DOAP (2)MI 8.5, 8.6
performing a Hand Hygiene& PPE-1
blood transfusion
Thursday L6 L13 14 A SGD 9 PA7.4 Paraneoplastic Syndrome
24-10-2024 SU 5.3 Ph 1.14
Differentiate the various types of B SGD (10) PH 1.6
Anticholinergic Drugs
wounds ,plan and observe
PvPI
management of wounds)
C TUTORIAL(1) MI 1.1
Overview of bact. Infections. Gram
positive bacilli identification scheme
Friday L8 L14 16 B SGD 9 PA7.4 Paraneoplastic Syndrome
25-10-2024 OG 4.1 C SGD (12) PH 2.2
MI 1.7
Placenta functions and
Complement System Intro Pharmacy
abnormalities, Amniotic fluid:
formation, composition, ATUTORIAL(1) MI 1.1
importance and abnormalities Overview of bact. Infections. Gram
positive bacilli identification scheme
Saturday L10 L15 14 C SGD 9 PA7.4 Paraneoplastic Syndrome
26-10-2024 MI 1.7
FM 3.8
Mechanical injuries Part 2 Antigen & Antibody A SGD (10) PH 1.6
Reactions PvPI
BTUTORIAL(1) MI 1.1
Overview of bact. Infections. Gram
positive bacilli identification scheme
Week 9 07:30 - 08:30 AM 08:30 - 09:30 AM 09:30 - 11:30 AM 11:30 AM- 12:30 - 01:30 01:30 - 02:30 PM 02:30 - 03:30 PM
12:30 PM PM

Monday AETCOM 2.3 Health care as L17 15 A SGD 10PA11.2 ChildhoodTumours L5 L6 SDL2a
28-10-2024 right Seminar PA9.2 CM 5.7+5.8 CM 3.1
Hypersensitivity CM 5.5 Food Hygiene Noise pollution
B SGD (11) PH 1.6 Nutritional
PvPI (Revision) Assessment &
C TUTORIAL(2)MI 1.1 Surveillance
Overview of viral infections.
Diagnosis of viral infections
Break
Tuesday L11 L18 17 B SGD 10PA11.2 ChildhoodTumours Clinical Posting
29-10-2024 PA9.3
FM 3.9 HLA System
Firearm Injuries C DOAP (5) PH 2.2
ORS
A TUTORIAL(2)MI 1.1
Overview of viral infections
Diagnosis of viral infections
Wednesday L8 IM23.3 Discuss and L14 15 C SGD 10PA11.2 Childhood Tumours
30-10-2024
describe the aetiology, PH 1.15
cause, clinical Skeletal Muscle relaxants A SGD (11) PH 1.6
manifestation, PvPI (Revision)
complication, diagnosis B TUTORIAL(2)MI 1.1
and management of Overview of viral infections
common vitamin Diagnosis of viral infections
deficiencies
Thursday HOLIDAY
31-10-2024

Friday HOLIDAY
01-11-2024

Saturday SGD 6 L16 16 C SGD 10PA11.2 ChildhoodTumours

02-11-2024
 FM 2.34 MI 1.7 A SGD (12) PH 2.2
Mass Disaster Situation Structure & functions of Intro Pharmacy
immune system REVISION HAI

Week 10 07:30 - 08:30 AM 08:30 - 09:30 AM 09:30 - 11:30 AM 11:30 AM- 12:30 - 01:30 01:30 - 02:30 PM 02:30 - 03:30 PM
12:30 PM
PM

Monday AETCOM 2.3 Health care as right Seminar L19 16 A SGD 11PA11.1 Genetic Abn in Child FAP Field Visit III
04-11-2024 PA9.4,9.5,9.7
Autoimmunity
B SGD (12) PH 2.2
Intro Pharmacy
C SGD (12)MI1.7
Agglutination & Precipitation Break

Tuesday SGD 7 L20 18 B SGD 11PA11.1 Genetic Abn in Child Clinical Posting
05-11-2024 PA27.1
FM 4.11
Atherosclerosis C DOAP (6) PH 2.2
Euthansia
ORS (Revision)
A SGD (12)MI1.7
Agglutination & Precipitation
Wednesday L15 17 C SGD 11PA11.1 Genetic Abn in Child
06-11-2024
L9 IM16.2 Describe and
discuss the acute systemic PH 1.17
Local anaesthetics A DOAP (5) PH 2.2
consequences of diarrhoea ORS
including its impact on fluid B SGD (12)MI1.7
balance Agglutination & Precipitation

Thursday L7 L16 [AITO -IHD] 17 A SGD 12PA11.3 Storage Disorders

07-11-2024 SU6.1 PH 1.31
SURGICAL INFECTIONS Define and Dyslipidaemia B DOAP (5) PH 2.2
describe the etiology and ORS
pathogenesis of surgical infections
C(SGD 13) MI 1.7
ELISA, RIA,IFA
Friday L9 L17 19 B SGD 12PA11.3 Storage Disorders
08-11-2024 OG 4.1 MI 1.8
Embryogenesis and Immune Response C SGD (13) PH 4.2
Development of fetus, Fetal Animal Ethics
physiology A(SGD 13) MI 1.7
 ELISA, RIA,IFA
Saturday L12 L18 18 C SGD 12PA11.3 Storage Disorders
09-11-2024
FM 3.13 MI 1.11 A DOAP (6) PH 2.2
Sexual offences Part 1 Tumor immunology ORS (Revision)
B(SGD 13) MI 1.7
ELISA, RIA,IFA

Week 11 07:30 - 08:30 AM 08:30 - 09:30 09:30 - 11:30 AM 11:30 AM- 12:30 - 01:30 - 02:30 02:30 - 03:30 PM
AM 12:30 PM 01:30 PM
PM

Monday L21[AITO -IHD] 18ADOAP 8[AITO -IHD]PA27.8 Cardiac Function L7 L8 SDL 2b

11-11-2024 PA27.5 CM 5.6 CM 3.1
AETCOM 2.4 CM 5.7+5.8 National
IHD Noise pollution
B DOAP (6) PH 2.2 Food Nutrition policy
Working in ahealth care team Tag Submission
along ORS (Revision) fortification + Mid-Day
Meal+
C (PANDEMIC Module 3) PM 2.3 Sample and food AnemiaMukt
Collection, Serologic tests cards, additives Bharat
Presentation (Seminar 2) Break
Tuesday L13 L22 20 B DOAP 8[AITO -IHD]PA27.8 Cardiac Function Clinical Posting
12-11-2024 PA27.4,27.6
FM 3.14 Rh Fever,
Sexual offences Part 2 Endocarditis C DOAP (7) PH 4.2
Intro Experimental Ph
A (PANDEMIC Module 3) PM 2.3 Sample
Collection, Serologic tests cards,
Presentation (Seminar 2)
Wednesday L10 IM16.1 Describe , L17 [AITO -IHD] 19 C DOAP 8[AITO -IHD]PA27.8 Cardiac Function
13-11-2024
discuss the aetiology of PH 1.25
acute and chronic diarrhoea Antiplatelets A SGD (13) PH 4.2
including infectious and agents Animal Ethics
non-infectious B (PANDEMIC Module 3) PM 2.3 Sample
causes.Intg:microbiology Collection, Serologic tests cards,
Presentation (Seminar 2)
Thursday L8 L18 [AITO -IHD] 19 A DOAP 8[AITO -IHD]PA27.8 Cardiac Function
14-11-2024 (Revision)
 SU6.2 PH 1.25 B SGD (13) PH 4.2
SURGICAL INFECTIONS Define Anti- Animal Ethics
and describe the etiology and coagulants REVISION HAI
pathogenesis of surgical
infections
Friday
15-11-2024

Saturday
16-11-2024

Week 12 07:30 - 08:30 AM 08:30 - 09:30 AM 09:30 - 11:30 AM 11:30 AM- 12:30 - 01:30 - 02:30 PM 02:30 – 03:30
12:30 PM 01:30 PM
PM

Monday L23 20 A SGD 5.1 Wound healing L9 L10 SDL 3a

18-11-2024 PA27.7,27.9
AETCOM 2.4 Pericarditis, CM 5.6 CM 5.6 CM 3.1
Cardiomyopathy B DOAP (7) PH 4.2 ICDS Vitamin A Water
Working in a health care team Tag
along
Intro Experimental Ph Prophylaxis + Pollution
C DOAP (3)MI 1.2 Fluorosis +
ZN staining1 IDD
Tuesday L24 21 B SGD 5.1 Wound healing Break Clinical Posting
SGDS 8
19-11-2024 PA27.3
FM 2.29 Heart Failure
Courts Procedures.
C DOAP (8) PH 4.2
Experimental equipments
A DOAP (3)MI 1.2
ZN staining1
Wednesday L11 L19 20 C SGD 5.1 Wound healing
20-11-2024
IM9.1 classification of PH 1.28 [AITO -IHD]
Anti-anginal agents A DOAP (7) PH 4.2
anemia based on red Intro Experimental Ph
blood cell size and B DOAP (3)MI 1.2
reticulocyte count Intg: ZN staining1
pathology
Thursday L9 L20 21 A SGD 9.6 HIV/AIDS
21-11-2024 SU7.2 PH 1.28 [AITO -IHD]
Surgical audit and research Pharmacotherapy of MI B DOAP (8) PH 4.2
Experimental equipments
C DOAP (4)MI 1.2
KOH mount preparation
Tutorial (3)
Lab diagnosis of fungal infections

Friday L10 L19 22 B SGD 9.6 HIV/AIDS

22-11-2024 OG 6.1
MI 1.10 C DOAP (9) PH 4.2
Diagnosis of
pregnancy Hypersensitivity I Drugs on rabbits eye
A DOAP (4)MI 1.2
KOH mount preparation
TutorialTutorial (3)
Lab diagnosis of fungal infections

Saturday AITO -IHD L20 21 C SGD 9.6 HIV/AIDS

23-11-2024 Integrated Session
PA 27.5 , 27.8 PH 1.28 MI 1.10
PY 5.4-5.6 AN 67.1, 67.2 Hypersensitivity II A DOAP (8) PH 4.2
Experimental equipments
B DOAP (4)MI 1.2
KOH mount preparation
TutorialTutorial (3)
Lab diagnosis of fungal infections

PART COMPLETION TEST 1 Examinations 25-11-2024 to 07-12-2024

Monday PART COMPLETION TEST 1

25-11-2024
Tuesday PART COMPLETION TEST 1
26-11-2024
Wednesday PART COMPLETION TEST 1
27-11-2024
Thursday PART COMPLETION TEST 1
 28-11-2024
Friday PART COMPLETION TEST 1
29-11-2024
Saturday PART COMPLETION TEST 1
30-11-2024
Sunday
1-12-2024
Monday PART COMPLETION TEST 1
2-12-2024
Tuesday PART COMPLETION TEST 1
3-12-2024
Wednesday PART COMPLETION TEST 1
4-12-2024

Thursday PART COMPLETION TEST 1

5-12-2024
Friday HOLIDAY
6-12-2024
Saturday PART COMPLETION TEST 1
07-12-2024

Week15 07:30 - 08:30 AM 08:30 - 09:30 AM 09:30 - 11:30 AM 11:30 AM- 12:30 - 01:30 - 02:30 PM 02:30 - 03:30
12:30 PM 01:30 PM
PM

Monday L25 [AITO-Anemia] 22 A SGD 15PA12.3 Obesity FAP Field Visit IV

09-12-2024 PA13.3,13.4
AETCOM 2.4 Anemia
B DOAP (9) PH 4.2
Working in a health care team Tag
along Drugs on rabbits
eye
C DOAP (5) MI 1.2
ZN Staining-2 Break
Tuesday SGD 10 L26 [AITO-Anemia] 23 B SGD 15PA12.3 Obesity Clinical Posting
10-12-2024 PA14.1,14.2
FM 2.30 Iron, Micro Anemia
Latest Court Ammendments C DOAP (10) PH 4.2
Drugs on
rabbit’s eye
(Simulation)
A DOAP (5) MI 1.2
ZN Staining-2
Wednesday L12 L21 22 C SGD 15PA12.3 Obesity
11-12-2024
PH 1.24
Diuretic & Antidiuretics A DOAP (9) PH 4.2
Drugs on rabbits eye
 IM16.6 Distinguish b/w B DOAP (5) MI 1.2
diarrhoea and dysentery ZN Staining-2
based on clinical features

Thursday L10 L22 23 A SGD 13 12.1 Tobacco , Alcohol

12-12-2024 SU7.2-Principles and steps of [AITO-Anemia]
clinical research in general PH 1.35 B DOAP (10) PH 4.2
surgery Drugs on rabbit’s eye
Pharmacotherapy of
Anaemia (Simulation)
C SGD (14)
MI 8.8 Environmental Surveillance
Friday L11 SDL-1a 24 B SGD 13 12.1 Tobacco , Alcohol
13-12-2024 OG 6.1
Diagnosis of pregnancy
MI 1.9
Immunoprophylaxis C DOAP (11) PH 4.2
Drugs on dog’s BP
ASGD (14)
MI 8.8 Environmental Surveillance
Saturday SGD 11 SDL-1b 23 C SGD 13 12.1 Tobacco , Alcohol
14-12-2024
FM 2.22 MI 1.9
Mechanical asphyxia A DOAP (10) PH 4.2
Immunoprophylaxis
Drugs on rabbit’s eye
(Simulation)
BSGD (14)
MI 8.8 Environmental Surveillance

Week 16 07:30 - 08:30 AM 08:30 - 09:30 AM 09:30 - 11:30 AM 11:30 AM- 12:30 - 01:30 01:30 - 02:30 PM 02:30 - 03:30 PM
12:30 PM PM

Monday L27 [AITO-Anemia] 24 A SGD 14 12.2,12.3 Malnutrition, L11 L12 SDL 3b

16-12-2024 PA15.1,15.2 Obesity
AETCOM 2.4 Vit B12, Macro Anemia CM 11.1+11.3 CM 11.1+11.3 CM 3.1
B DOAP (11) PH 4.2 Occupational Occupational Water
Working in a health care team Tag along
Drugs on dog’s BP Health 1 Health 2 Pollution
C DOAP (6) Submission
MI 1.2 Gram Staining-2
TutorialTutorial (4) Break
: Identification of Gram +ve& Gram –
vecocci
Tuesday SGD 12 L28 [AITO-Anemia] 25 B SGD 14 12.2,12.3 Malnutrition, Obesity Clinical Posting
17-12-2024 PA16.1,16.2
 FM 3.11 Hemolytic Anemia C DOAP (12) PH 4.2
(AITO Anaemia)
Regional injuries. UK drugs on dog’s BP
A DOAP (6)
MI 1.2 Gram Staining-2
Tutoria Tutorial (4)
l: Identification of Gram +ve& Gram –
vecocci
Wednesday FEEDBACK SESSION PCT 1 L23 24 C SGD 14 12.2,12.3 Malnutrition, Obesity
18-12-2024
PH 1.26
ReninAngiotensin A DOAP (11) PH 4.2
System (RAS) Drugs on dog’s BP
B DOAP (6)
MI 1.2 Gram Staining-2
TutorialTutorial (4)
: Identification of Gram +ve& Gram –
vecocci
Thursday L11 L24 25 A SGD 17PA27.2 Aneurysm
19-12-2024
SU8.1 -Surgical ethics (Principles PH 1.27
and importance) Vasodilators-1 B DOAP (12) PH 4.2
UK drugs on dog’s BP
C DOAP (7)
MI 1.2
Stool Microscopy-1
Friday L12 L21 26 B SGD 17PA27.2 Aneurysm
20-12-2024 OG7.1
Physiological changes in
MI 1.10
C DOAP (13) PH 4.2
pregnancy : anatomical and Autoimmunity
Drugs on Dog’s BP - test
cardiovascular A DOAP (7)
MI 1.2
Stool Microscopy-1

Saturday SGD 9 L22 25 C SGD 17PA27.2 Aneurysm

21-12-2024
FM 2.22 MI 1.1
Mechanical asphyxia. Overview of A DOAP (12) PH 4.2
UK drugs on dog’s BP
Parasitic
B DOAP (7)
Infections MI 1.2
Stool Microscopy-1
Week 17 07:30 - 08:30 AM 08:30 - 09:30 AM 09:30 - 11:30 AM 11:30 AM- 12:30 - 01:30 01:30 - 02:30 PM 02:30 - 03:30 PM
12:30 PM PM

Monday PCT-1 FEEDBACK 26 A SGD 18PA27.10 Syphilis BREAK L13 L14 SDL 4a
23-12-2024 CM 11.1+11.3 CM 11.1+11.3 CM 10.4
AETCOM 2.4 SESSION B DOAP (13) PH 4.2 Growth Chart
Occupational Occupational
Working in a health care team Tag along Drugs on Dog’s BP - test
Health 3 Health 4
CDOAP (8)
MI 1.2 ZN staining-3
Tuesday SGD 13 L29 [AITO-Anemia] 27 B SGD 18PA27.10 Syphilis
24-12-2024 PA16.3
FM 3.27 Sickle Anemia, C SGD (14) PH 3.1
Criminal Abortion And MTP ACT Thalassemia Prescription Writing 1
A DOAP (8)
MI 1.2 ZN staining-3
Wednesday HOLIDAY
25-12-2024

Thursday L12 PCT 1 FEEDBACK 28 A SGD 18PA27.10 Syphilis (Revision) BREAK

26-12-2024
SU 8.2 -Medicolegal issues in SESSION
surgical practice
B SGD (14) PH 3.1
Prescription Writing 1
CDOAP (9)
MI 1.2 Stool Microscopy-2

Friday
27-12-2024
HOLIDAY

Saturday SGD 14 PCT 1 FEEDBACK 26 C SGD 18PA27.10

28-12-2024 SESSION Syphilis
FM 3.28
Evidences of abortion A DOAP (13) PH 4.2
Drugs on
Dog’s BP -
test
BDOAP (9)
MI 1.2 Stool Microscopy-2
WINTER VACATIONS – 30/12/2024 TO 04/01/2025

Week 19 07:30 - 08:30 AM 08:30 - 09:30 AM 09:30 - 11:30 AM 11:30 AM- 12:30 - 01:30 01:30 - 02:30 PM 02:30 - 03:30 PM
12:30 PM PM

Monday HOLIDAY
06-01-2025

Tuesday SGD 15 L30 [AITO-Anemia] 28B SGD 19PA13.2 Anticoagulants

07-01-2025 PA16.4
FM 3.12 Acq. Hemolytic Anemia
Regional injuries. C SGD (15) PH 3.1 Clinical Posting
Prescription Ex1
A DOAP (10) MI 8.5, 8.6
Hand Hygiene & PPE-2
Wednesday L13 [AITO-Anemia] L25 27 C SGD 19PA13.2 Anticoagulants
08-01-2025
IM9.7 Describe and discuss the PH 1.27 A SGD (14) PH 3.1
meaning and utility of various Vasodilators-2 Prescription Writing 1
components of hemogram Intg:
B DOAP (10)MI 8.5, 8.6
pathology Hand Hygiene & PPE-2
Thursday L13 L26 29A SGD 19PA13.2 Anticoagulants Break
09-01-2025
SU 14.1 -Describe aseptic PH 1.27
techniques, sterilization and Anti-hypertensive B SGD (15) PH 3.1
disinfection agents Prescription Ex1
C SGD (15)MI 1.1
Fever of Unknown Origin
Discussion of all causes
Friday L13 L23 29 B SGD18 23.2 Body fluids
10-01-2025 OG 7.1
MI 8.5, 8.6
Physiological changes in C SGD (16) PH 3.1
HAIs & methods
pregnancy: hematological,
of prevention Prescription Ex2
respiratory and metabolic
A SGD (15)MI 1.1
Fever of Unknown Origin
Discussion of all causes
Saturday SGD16 L24 28 C SGD18 23.2 Body fluids
11-01-2025
FM 4.24, 4.21 , FM 4.3, 4.4, 4.5 MI 2.1, 2.2
Rights Privileges And Duties Of Rheumatic A SGD (15) PH 3.1
RMP. Role Of MCI Fever & Prescription Ex1
B SGD (15)MI 1.1
Infective Fever of Unknown Origin
Endocarditis Discussion of all causes

Week 20 07:30 - 08:30 AM 08:30 - 09:30 AM 09:30 - 11:30 AM 11:30 AM- 12:30 12:30 - 01:30 01:30 - 02:30 PM 02:30 - 03:30 PM
PM PM

Monday L31 [AITO-Anemia] 30 A SGD18 23.2 Body fluids L15 SDL 4b SDL 5a
13-01-2025 PA17.1,17.2 CM 11.1+11.3 CM 10.4 CM 5.2+5.4
AETCOM 2.4 Aplastic Anemia, BMA B SGD (16) PH 3.1 Occupational Growth Chart Own dietary
Working in a health care team Tag Prescription Ex2 Submission Assessment
along
Break Health 5
C SGD (16)
MI1.1,8.1,8.15Misc.Bacterial BSI
Tuesday SGD 17 L32 30 B DOAP7 PA23.1 Urine examination
14-01-2025 PA18.2
FM 3.29 Leukemia C SGD (17) PH 3.1
Child abuse and battered baby Prescription test 1 Clinical posting
syndrome A SGD
(16)MI1.1,8.1,8.15Misc.Bacterial BSI
Wednesday L14 IM8.1 epidemiology, L27 29 C DOAP7 PA23.1 Urine examination
15-01-2025
aetiology and the prevalence of PH 1.29
primary and secondary Pharmacotherapy of A SGD (16) PH 3.1
hypertension Intg: CHF Prescription Ex2
pathology, physiology B SGD
(16)MI1.1,8.1,8.15Misc.Bacterial BSI
Thursday L14 L28 31A DOAP7 PA23.1 Urine examination
16-01-2025
SU 15.1 - Biohazard disposal PH 1.30
Describe classification of Antiarrhythmic B SGD (17) PH 3.1
hospital waste and appropriate agents 1 Prescription test 1
methods of disposal C SGD (17) MI 3.3,3.4, 8.15
Widal Test, Salmonella & NTS

L14 L25 [AITO-Anemia] 31 B SGD 20[AITO-Anemia] PA13.1

Friday OG 7.1 Hematopoiesis
MI 2.4
17-01-2025
Anaemia C SGD (18) PH 3.1
Prescription test 2
 Physiological changes in A SGD (17) MI 3.3,3.4, 8.15
pregnancy: renal, Widal Test, Salmonella & NTS
gastrointestinal, endocrine
SGD 18 L26 30 C SGD 20[AITO-Anemia] PA13.1
Saturday Hematopoiesis
FM 4.18 MI 3.3, 3.4
18-01-2025
Medical negligence Enteric Fever A SGD (17) PH 3.1
Prescription test 1
B SGD (17) MI 3.3,3.4, 8.15
Widal Test, Salmonella & NTS

07:30 - 08:30 AM 08:30 - 09:30 AM 09:30 – 11 u:30 AM 11:30 AM- 12:30 - 01:30 - 02:30 PM 02:30 - 03:30 PM
12:30 PM 01:30 PM
Week 21

Monday L33 32 A SGD 20[AITO-Anemia] PA13.1 Hematopoiesis SDL 5b AETCOM 2.4 SPORTS 1
20-01-2025 PA18.2 CM 5.2+5.4 Reflective Writing
AETCOM 2.4 Leukemia Own dietary
B SGD (18) PH 3.1
Working in a health care team -SGD Assessment
Prescription test 2 Submission
C SGD (18)MI 1.1, 8.15
Systemic Candidiasis
Tuesday SGD 19 L34 32 B DOAP 9[AITO-Anemia]PA13.5 PBF Break 27
21-01-2025 PA18.3
FM 4.19 Leukemia
28 Clinical Posting
Consent C DOAP (14)PH 3.2 30
Critical app Prescrip Ex1
A SGD (18)MI 1.1, 8.15
Systemic Candidiasis
Wednesday L15 IM8.2 Describe and discuss L29 31 C DOAP 9[AITO-Anemia]PA13.5 PBF
22-01-2025
the pathophysiology of PH 1.30
hypertension Intg: pathology, Antiarrhythmic A SGD (18) PH 3.1
physiology agents 2 Prescription test 2
B SGD (18)MI 1.1, 8.15
Systemic Candidiasis
Thursday L15 L30 33 A DOAP 9[AITO-Anemia]PA13.5 PBF
23-01-2025
SU 17.1- Describe the principles PH 1.27
of first aid Shock
B DOAP (14)PH 3.2
Critical app Prescrip Ex1
C DOAP(11 ) MI 1.2
 Gram Staining-3
Friday L15 33 B DOAP 10[AITO-Anemia]PA14.3 PBF in
24-01-2025 OG 8.1,8.6-8 SDL 2a Microcytic An
Antenatal care MI1.2,2.4,8.15
Bloodstream C DOAP (15) PH 3.2
Infections Critical app Prescrip Ex2
A DOAP(11 ) MI 1.2
Gram Staining-3
Saturday SGD 20 L27MI 8.16 32 C DOAP 10[AITO-Anemia]PA14.3 PBF in
25-01-2025 Microcytic An
FM 3.30 ,3.31 National
Torture Health A DOAP (14)PH 3.2
Programmes Critical app Prescrip Ex1
for B DOAP(11 ) MI 1.2
Communicable Gram Staining-3
Diseases

Week 22 07:30 - 08:30 AM 08:30 - 09:30 AM 09:30 - 11:30 AM 11:30 AM- 12:30 - 01:30 01:30 - 02:30 PM 02:30 - 03:30 PM
12:30 PM PM

Monday L35 34 ADOAP 10[AITO-Anemia]PA14.3 AETCOM 2.4 SPORTS 2 SPORTS 3

27-01-2025 PA19.1,19.4 PBF in Microcytic An Manual
AETCOM 2.4 LAD, HL, NHL Submission
Working in a health care team -SGD Leukemia B DOAP (15) PH 3.2
Critical app Prescrip Ex2
C SGD (19) MI 1.1,8.15
Filoviral Infections
Break
Tuesday SGD 21 L36 34 B DOAP 11[AITO-Anemia] Clinical Posting
28-01-2025 PA19.6,21.1 PA15.3 PBF in Macrocytic An
FM 3.3
Splenomegaly,
Mechanical injuries C DOAP (16) PH 3.8/5.2
Hemostasis
Proper and Optimal use of
medicine
A SGD (19) MI 1.1,8.15
Filoviral Infections

Wednesday L16 IM17.1 Define and classify L31 33 C DOAP 11[AITO-Anemia]

29-01-2025 PA15.3 PBF in Macrocytic An
headache and describe the PH 1.16
presenting features, Histamine A DOAP (15) PH 3.2
 precipitating factors, Critical app Prescrip Ex2
aggravating and relieving B SGD (19)MI 1.1,8.15
factors Intg: human anatomy Filoviral Infections

L16 L32 35A DOAP 11[AITO-Anemia]

Thursday SU 18.1 -Skin and PH 1.16 PA15.3 PBF in Macrocytic An
30-01-2025
subcutaneous tissue-clinical Serotonin
B DOAP (16) PH 3.8/5.2
features of various cutaneous
Proper and Optimal use of
and subcutaneous infections
medicine
C SGD (20) MI 8.2
Opportunistic infections
Friday L16 SDL 2b 35 B SGD 21[AITOia]
31-01-2025 PA15.4 Megalo/Non-Megalo
OG 13.1 MI1.2,2.4,8.15
Normal labour Bloodstream C DOAP (17) PH 5.3
Infections Adherence to medicine
A SGD (20) MI 8.2
Opportunistic infections
Saturday AITO-Anemia L28 34 C SGD 21[AITO-Anemia]
01-02-2025 Integrated Session PA15.4 Megalo/Non-Megalo
IM 9.1,9.7 MI 1.1, 8.15
PH 1.35, MI 12.4 Rickettsial A DOAP (16) PH 3.8/5.2
PA13.3 ,4,5, 14.1,2,3, 15.1,2,3,4. Infections Proper and Optimal use of
16.1-6 medicine
B SGD (20)MI 8.2
Opportunistic infections

Week 23 07:30 - 08:30 AM 08:30 - 09:30 AM 09:30 - 11:30 AM 11:30 AM- 12:30 - 01:30 01:30 - 02:30 PM 02:30 - 03:30 PM
12:30 PM PM

Monday AETCOM 2.5 Bioethics Case study on L37 36 A SGD 21[AITO-Anemia]PA15.4 Megalo/Non-Megalo FAP Field Visit V
03-02-2025 autonomy and decision-making PA21.2 Break
introduction to case ITP, Hemophilia B DOAP (17) PH 5.3
Adherence to medicine
C DOAP (12)MI 1.2
Gram Staining-4
Tuesday SGD 22 L38 36 B SGD 22[AITO-Anemia] PA16.5 PBF In Hemolytic An Clinical Posting
04-02-2025 PA21.4,21.5 Clinical Posting
FM 2.11, FM 2.13, 2.14 DIC, Vit K
Autopsy procedures.
Post Mortem Examination And
C DOAP (18) PH 5.4
Obscure Autopsies.
Cost of t/t, compliance
 A DOAP (12)MI 1.2
Gram Staining-4
Wednesday L17 IM3.2 Discuss and describe the L33 35 C SGD 22[AITO-Anemia] PA16.5 PBF In Hemolytic
05-02-2025 An
aetiologies of various kinds of PH 1.16
pneumonia and their microbiology Prostaglandins A DOAP (17) PH 5.3
depending on the setting and Adherence to medicine
immune status of host. B DOAP (12)MI 1.2
Intg:microbiology Gram Staining-4
Thursday L17 L34 37 A SGD 22[AITO-Anemia] PA16.5 PBF In Hemolytic
06-02-2025 An
SU 25.1-Comparative and Surgical PH 1.16
anatomy of breast, Investigations of NSAIDS B DOAP (18) PH 5.4
breast disease, Triple assessment Cost of t/t, compliance
C DOAP (13)MI 2.5,2.6,8.16
PBF for Malaria
Friday L17 L29 37 B DOAP 12[AITO-Anemia]PA16.6 Identify HemolyticAn
07-02-2025 OG 22.1
MI 2.7, 8.15,
Vaginal discharge 8.16
HIV-I C DOAP (19) PH 5.3/5.4
Adherence to medicine& Cost of t/t,
compliance
A DOAP (13)MI 2.5,2.6,8.16
PBF for Malaria
Saturday SGD 23 L30 36 C DOAP 12[AITO-Anemia]PA16.6 Identify HemolyticAn
08-02-2025
FM 1.9 MI 2.7,
Importance of documentation in 8.15, 8.16 A DOAP (18) PH 5.4
medical practice. HIV-II Cost of t/t, compliance
B DOAP (13)MI 2.5,2.6,8.16
PBF for Malaria

Week 24 07:30 - 08:30 AM 08:30 - 09:30 AM 09:30 - 11:30 AM 11:30 AM- 12:30 - 01:30 01:30 - 02:30 PM 02:30 - 03:30 PM
12:30 PM PM
Monday AETCOM 2.5 Bioethics Case L39 38 A DOAP 12[AITO-Anemia]PA16.6 B SGD (21)MI 2.5,2.6,8.16 L32 MI
10-02-2025 study on autonomy and decision- PA22.1 Identify HemolyticAn Malaria II
making SDL Blood Group
Systems B DOAP (19) PH 5.3/5.4
Adherence to medicine& Cost
of t/t, compliance
C SGD (21)MI 2.5,2.6,8.16
Break
Malaria II
Tuesday L14 L40 38 B SGD 23PA19.2 TB Clinical Posting
11-02-2025 PA22.4,22.5 Blood Compo, Lymphadenopathy
FM2.10, 2.16 Transfusion Inf
Time since death & PM of C DOAP (20) PH 3.3
mutilated bodies Drug promotional liter
A SGD (21)MI 2.5,2.6,8.16
Malaria II
Wednesday HOLIDAY
12-02-2025

Thursday L18 L35 39 A SGD 23PA19.2 TB

13-02-2025 Lymphadenopathy
SU 28.5 -Describe the applied PH 1.16
anatomy and physiology of Gout B DOAP (20) PH 3.3
esophagus . Drug promotional liter
C DOAP (14)MI 2.5,2.6,8.16PBF
for filariasis & LD bodies
Friday L18 39 B SGD 23PA19.2 TB
14-02-2025 OG 9.1 SDL 3a Lymphadenopathy (Revision)
Abortions MI 1.1 ,8.15 C DOAP (21) PH 3.3
Viral Hemorrhagic Fever Drug prom liter ex 1
A DOAP (14) MI 2.5,2.6,8.16PBF
for filariasis & LD bodies
Saturday SGD 24 L31 37 C SGD 23PA19.2 TB
15-02-2025 Lymphadenopathy
FM 2.12 MI 2.5,1.1,8.65
Procedures to conduct MLC Leishmaniasis&Trypanosomiasis A DOAP (19) PH 5.3/5.4
and PMR. Adherence to medicine& Cost
of t/t, compliance
B DOAP (14)MI 2.5,2.6,8.16PBF
for filariasis & LD bodies
Week 25 07:30 - 08:30 AM 08:30 - 09:30 AM 09:30 - 11:30 AM 11:30 AM- 12:30 - 01:30 PM 01:30 - 02:30 PM 02:30 - 03:30 PM
12:30 PM
Monday AETCOM 2.5 Bioethics Case study on L41 40 A DOAP12 19.3 TB LAD 41 A SGD 24PA24.5 TB Intestine L 35 MI
17-02-2025 autonomy and decision-making SDL PA22.6,22.7
Transfusion Rx, Auto
Microscopy
Transfusion B DOAP (21) PH 3.3 B SGD (19)PH 1.4
Drug prom liter ex 1 Tutorial General Pharma
C (Pandemic Module 4) 40 C
PM 2.1 Infection Control
MI 1.6 Antimicrobial Resistance & Practical file and log book checking
Break
Antimicrobial Stewardship
Tuesday SGD 25 L42 40 B DOAP12 19.3 TB LAD Clinical Posting
18-02-2025 PA26.3
FM 2.15, 2.35 Microscopy
Obstructive Airway
Custodial autopsies Ds. C DOAP(22) PH 3.3
Professionalism While Drug prom liter ex 2
Conducting Autopsies. A(Pandemic Module 4)
PM 2.1 InfectionControl
MI 1.6 Antimicrobial Resistance &
Antimicrobial Stewardship
Wednesday L18 [AITO-Diabetes] L36 38 C DOAP12 19.3 TB LAD
19-02-2025
IM11.1 Define and classify PH 1.16 Microscopy
diabetes Rheumatoid A DOAP (20) PH 3.3
Arthritis Drug promotional liter
B (Pandemic Module 4)
PM 2.1 Infection Control
MI 1.6 Antimicrobial Resistance &
Antimicrobial Stewardship
Thursday L19 L37 42A SGD 24PA24.5 TB Intestine (Revision)
20-02-2025
SU 28.7 -Describe the anatomy PH 1.37
and physiology of Stomach Pituitary B DOAP(22) PH 3.3
hormones 1 Drug prom liter ex 2
C DOAP (15)MI 1.2
Stool Microscopy- 3& Modified ZN

Friday L19 41 B SGD 24PA24.5 TB

21-02-2025 SDL 3b Intestine
OG 19.1, 19.2
MI 1.1 ,8.15 C DOAP(23) PH1.59, 3.7
Essential Medicine /EML
 Normal puerperium and Viral A DOAP (15)MI 1.2
complications of puerperium, Hemorrhagic Stool Microscopy- 3& Modified ZN
puerperal contraception Fever
Saturday SGD 26 L32 39 C SGD 24PA24.5 TB
22-02-2025 Intestine
FM 2.18,2.19 MI 2.5,2.6,8.16
Crime Scene Investigation Filariasis A DOAP (21) PH 3.3
Drug prom liter ex 1
B DOAP (15)MI 1.2
Stool Microscopy- 3& Modified ZN

Week 26 07:30 - 08:30 AM 08:30 - 09:30 AM 09:30 - 11:30 AM 11:30 AM- 12:30 - 01:30 01:30 - 02:30 PM 02:30 - 03:30 PM
12:30 PM PM
Monday AETCOM 2.5 Bioethics Case study on L43 43 A SGD25 18.1 Leucocytosis 42 B SPORTS 4
24-02-2025 autonomy and decision-making Anchoring PA26.5
Lecture Occupational Lung B DOAP(23) PH1.59, 3.7 C SGD (19)PH 1.4
Diseases
Essential Medicine /EML Tutorial General Pharma
C SGD (22) MI 3.5 42 A
Food Poisoning Practical file and log book
Break checking
Tuesday SGD 27 L44 [AITO- 43 B SGD25 18.1 Leucocytosis Clinical Posting
25-02-2025 Diabetes]
FM 2.8
PA32.4
Post-mortem changes Diabetes
C DOAP (24) PH 3.7
Essential medicine exercise
A SGD (22)MI 3.5
Food Poisoning
Wednesday HOLIDAY
26-02-2025

Thursday L20 L38 44 A DOAP 14PA20.1 Myeloma (Revision)

27-02-2025
SU 28.7-Describe the anatomy and PH 1.37
physiology of Stomach Pituitary B DOAP (24) PH 3.7
hormones 2 Essential medicine exercise
C SGD (23)MI3.1,3.2
Diarrheagenic E.coli
Friday L20 L33 44 B DOAP 14PA20.1 Myeloma
28-02-2025 OG 17.1 MI 1.1, 8.15
Lactation Systemic C SGD (20) PH 1.8
Mycoses Intro drug interactions
A SGD (23) MI3.1,3.2
Diarrheagenic E.coli
Saturday SGD 28 L34 40 C SGD25 18.1 Leucocytosis
01-03-2025
FM 4.13 MI 3.1,3.2
Social Aspects Of Mlc Bacillary A DOAP(22) PH 3.3
Dysentery Drug prom liter ex 2
B SGD (23)MI3.1,3.2
Diarrheagenic E.coli

Week 27 07:30 - 08:30 AM 08:30 - 09:30 AM 09:30 - 11:30 AM 11:30 AM- 12:30 12:30 - 01:30 01:30 - 02:30 PM 02:30 - 03:30 PM
PM PM
Monday AETCOM 2.5 Bioethics Discussion and L45 45 A DOAP 15PA19.7 Spleen Specimen FAP Field Visit VI
03-03-2025 closure of case PA24.1 B SGD (20) PH 1.8
Oral Cancers
Intro drug interactions
CSGD (24) MI 3.1,3.2,3.6
Helicobacter & Campylobacter
Tuesday SDL 1a L46 45B DOAP 15PA19.7 Spleen Specimen BREAK
04-03-2025 SDL 1a
PH 1.64
PA22.2 Compatibility C SGD (21)PH 1.8
Drug Discovery Testing
Desirable drug interactions
A SGD (24) MI 3.1,3.2,3.6
Helicobacter & Campylobacter
Wednesday L19 [AITO-Diabetes] L39 41 C DOAP 14PA20.1 Myeloma
05-03-2025
IM11.2 Epidemiology and PH 1.38 +
pathogenesis and risk factors and Corticosteroids DOAP 15PA19.7 Spleen Specimen
clinical evolution and economic A DOAP(23) PH1.59, 3.7
impact of type 1 Essential Medicine /EML
diabetes and type 2 diabetes. B SGD (24) MI 3.1,3.2,3.6
Helicobacter & Campylobacter
Thursday L40 [AITO-Diabetes] 46A DOAP 16PA19.5 Hodgkin Lymphoma
06-03-2025
SPORTS 5
PH 1.36 B SGD (21)PH 1.8
Diabetes Desirable drug interactions
Mellitus 1 C SGD (25) MI 3.1,3.2,3.6
Clostridium infection
 Lab Diagnosis of anaerobic infection

Friday SPORTS 6 L35 46 B DOAP 16PA19.5 Hodgkin Lymphoma

07-03-2025
MI 3.1,3.2
Amoebic C SGD (22) PH 1.8
Dysentery Undesirable drug inter
A SGD (25) MI 3.1,3.2,3.6
Clostridium infection
Lab Diagnosis of anaerobic infection
Saturday PANDEMIC Module 2.5 L36 42 C DOAP 16PA19.5 Hodgkin Lymphoma
08-03-2025 Therapeutic strategies MI 3.1,3.2
including new drug Cholera A DOAP (24) PH 3.7
development Essential medicine exercise
B SGD (25) MI 3.1,3.2,3.6
Clostridium infection
Lab Diagnosis of anaerobic infection

Week 28 07:30 - 08:30 AM 08:30 - 09:30 AM 09:30 - 11:30 AM 11:30 AM- 12:30 - 01:30 01:30 - 02:30 PM 02:30 - 03:30 PM
12:30 PM PM
Monday AETCOM 2.6 Bioethics Introduction to case L47 47 A SGD 26PA21.3 Platelet, Clotting 43 C SGD 27PA16.7 Cross Match SPORTS 7
10-03-2025 PA24.2 B SGD (22) PH 1.8 BREAK A SGD (19)PH 1.4
Peptic Ulcer
Undesirable drug inter Tutorial General Pharma
C SGD (26)MI 3.1,3.2Lactose
Fermenters B
Diagnostic scheme of LF & NLF Practical file and log book
checking
Tuesday SDL 1b L48 47 B SGD 26PA21.3 Platelet, Clotting
11-03-2025 PA24.4 + SGD 27PA16.7 Cross Match
PH 1.64
Carcinoma
Drug Discovery Stomach
C SGD (23)PH 1.8
Drug interactions test
A SGD (26) MI 3.1,3.2
Lactose Fermenters
Diagnostic scheme of LF & NLF
Wednesday L20 L41 [AITO-Diabetes] 44 C SGD 26PA21.3 Platelet, Clotting
12-03-2025
IM3.3Pathogenesis,presentation,natural PH 1.36
history and complications of Pneumonia. Diabetes Mellitus 2 A SGD (20) PH 1.8
Intg: pathology,microbiology Intro drug interactions
B SGD (26) MI 3.1,3.2
Lactose Fermenters
 Diagnostic scheme of LF & NLF

Thursday AITO-Diabetes L42 48 A SGD 27PA16.7 Cross Match

13-03-2025 Integrated Session PH 1.41
PA 32.4
PH 1.36, MI 11.1,11.2 Uterine relaxants B SGD (23)PH 1.8
and stimulants Drug interactions test
C SGD (27)MI 3.1,3.2
Non-Lactose Fermenters
Diagnosis of non-fermentors
Friday HOLIDAY
14-03-2025

Saturday PANDEMIC Module 2.5 L37 45 C SGD 27PA16.7 Cross Match

15-03-2025 Therapeutic strategies MI 3.1,3.2 A SGD (21)PH 1.8
including new drug development Viral Gastroenteritis Desirable drug interactions
(Pharmacology, General Medicine)
B SGD (27) MI 3.1,3.2
Non-Lactose Fermenters
Diagnosis of non-fermentors

PART COMPLETION TEST 2 FROM 17-03-2025 TO 28-03-2025

Monday PART COMPLETION TEST 2

17-03-2025
Tuesday PART COMPLETION TEST 2
18-03-2025
Wednesday PART COMPLETION TEST 2
19-03-2025
Thursday PART COMPLETION TEST 2
20-03-2025
Friday PART COMPLETION TEST 2
21-03-2025
Saturday PART COMPLETION TEST 2
22-03-2025
 Monday PART COMPLETION TEST 2
24-03-2025
Tuesday PART COMPLETION TEST 2
25-03-2025
Wednesday PART COMPLETION TEST 2
26-03-2025
Thursday PART COMPLETION TEST 2
27-03-2025
Friday PART COMPLETION TEST 2
28-03-2025
Saturday PART COMPLETION TEST 2
29-03-2025

Week 31 07:30 - 08:30 AM 08:30 - 09:30 AM 09:30 - 11:30 AM 11:30 AM- 12:30 12:30 - 01:30 01:30 - 02:30 PM 02:30 - 03:30 PM
PM PM

Monday HOLIDAY HOLIDAY

31-03-2025

Tuesday SDL 2a L49 48 B SGD 28PA32.7 Adrenal

01-04-2025 SDL 1b PA22.2 Insufficiency Clinical Posting
PH 1.43 Break
Rational Use of Drugs Compatibility Testing C DOAP (25) PH 3.5
P-drug list
A SGD (28)MI3.1,3.2,1.2,8.15
Intestinal Protozoa
L38 L43 46 C SGD 28PA32.7 Adrenal
Wednesday PH 1.37 Insufficiency
02-04-2025
MI 3.1,3.2,1.2,8.15
Intestinal Cestodes Sex hormones A SGD (22) PH 1.8
Undesirable drug inter
B SGD (28)MI3.1,3.2,1.2,8.15
Intestinal Protozoa
L50 L44 49 A SGD 28PA32.7 Adrenal
PA24.6 Insufficiency +
Thursday IBD PH 1.40 SGD 29PA32.8 Cushing’s Syndrome
03-04-2025
Erectile dysfunction
B DOAP (25) PH 3.5
P-drug list
C SGD (29)MI 3.1,3.2,1.2,8.15
Intestinal Nematodes
SPORTS 8 L39 49 B SGD 29PA32.8 Cushing’s
Friday Syndrome
MI
04-04-2025 C DOAP (26) PH 3.5
3.1,3.2,1.2,8.15
Intestinal P drug Ex1
A SGD (29)MI 3.1,3.2,1.2,8.15
Trematodes Intestinal Nematodes
PANDEMIC Module 2.5 SDL 4a 47 C SGD 29PA32.8 Cushing’s
Saturday Therapeutic strategies Syndrome
05-04-2025
MI 8.5, 8.6
including new drug development HAIs types & A SGD (23)PH 1.8
(Pharmacology, General Medicine) Drug interactions test
surveillance
B SGD (29)MI 3.1,3.2,1.2,8.15
Intestinal Nematodes

Week 32 07:30 - 08:30 AM 08:30 - 09:30 AM 09:30 - 11:30 AM 11:30 AM- 12:30 - 01:30 01:30 - 02:30 PM 02:30 - 03:30 PM
12:30 PM PM
Monday AETCOM 2.6 Bioethics SDL PCT2 FEEDBACK 50A SGD 30PA32.9 Adrenal Neoplasms FAP Field Visit VII
07-04-2025
SESSION
B DOAP (26) PH 3.5
P drug Ex1
C SGD(30) MI 3.1,3.2
Trematode inf. of Hepatobiliary system
Tuesday HOLIDAY Break 42
08-04-2025
43
40 Clinical Posting
Wednesday PCT2 FEEDBACK SESSION L45 48 C SGD 30PA32.9 Adrenal Neoplasms
09-04-2025
PH 1.34
Anti/diarrheal and A DOAP (25) PH 3.5
laxatives P-drug list
B SGD(30) MI 3.1,3.2
Trematode inf. of Hepatobiliary system
Thursday HOLIDAY
10-04-2025

L56 L40 50B SGD 30PA32.9 Adrenal

Friday PA26.1 Neoplasms
Pneumonia
MI 4.2,4.3
11-04-2025 C DOAP (27) PH 3.5
Introduction to
skin, soft tissue P drug Ex2
& Skeletal A SGD (31)MI 4.2,1.2
system Gas Gangrene

PANDEMIC Module 2.5 SDL 4b 49 C SGD 30PA32.9 Adrenal

Saturday Therapeutic strategies Neoplasms (Revision)
MI 8.5, 8.6
12-04-2025 including new drug A DOAP (26) PH 3.5
HAIs types &
development P drug Ex 1
(Pharmacology, General
surveillance
Medicine) B SGD (31) MI 4.2,1.2
Gas Gangrene

Week 33 07:30 - 08:30 AM 08:30 - 09:30 AM 09:30 - 11:30 AM 11:30 AM- 12:30 - 01:30 01:30 - 02:30 PM 02:30 - 03:30 PM
12:30 PM PM

Monday HOLIDAY
14-04-2025

Break
Tuesday SDL 2b L51 [AITO Thyroid ] 51 B [AITO Thyroid ]
15-04-2025 PA32.1,32.2,32.3 DOAP 17PA23.3 Thyroid FunctionTests Clinical Posting
PH 1.43
 Rational Use of Drugs Iodine, C DOAP (28) PH 3.5
Hypothyroidism
P drug test
A SGD (32) MI4.3,1.2,8.13,8.15
Misc.Bact. inf. of SST
Wednesday L41 PCT2 FEEDBACK 50 C [AITO Thyroid ]
16-04-2025 DOAP 17PA23.3 Thyroid FunctionTests
MI 4.3,8.15,8.16 SESSION
Leprosy
A DOAP (27) PH 3.5
P drug test
B SGD (32) MI4.3,1.2,8.13,8.15
Misc.Bact. inf. of SST
Thursday L52 L46 51 A [AITO Thyroid ]
17-04-2025 SDL 1b PA22.2 Compatibility Testing DOAP 17PA23.3 Thyroid FunctionTests
PH 1.39
Contraception
B DOAP (27) PH 3.5
P drug Ex2
C TUTORIAL(5)
MI 4.3,8.15
Other Cutaneous Viral infections
Friday HOLIDAY
18-04-2025

Saturday PANDEMIC Module 2.5 L42 51 C SGD 31 PA32.6 CA Pancreas

19-04-2025
Therapeutic strategies MI 4.3,8.15 A DOAP (27) PH 3.5
including new drug Viral P drug Ex2
development
(Pharmacology, General
Exanthems
Medicine) B TUTORIAL(5)
MI 4.3,8.15
Other Cutaneous Viral infections
Week 34 07:30 - 08:30 AM 08:30 - 09:30 AM 09:30 - 11:30 AM 11:30 AM- 12:30 - 01:30 01:30 - 02:30 PM 02:30 - 03:30 PM
12:30 PM PM

Monday AETCOM 2.6 Bioethics SDL 52 A SGD 31 PA32.6 CA Pancreas 53 ASGD 32PA36.1 Retinoblastoma SPORTS 9
21-04-2025 L53[AITO Thyroid ]
PA32.5 B DOAP (28) PH 3.5 B SGD (24) PH 1.13
Hyperthyroidism P drug test Tutorial Adr and Antiadr
Break
C (Pandemic Module 5) PM 2.1 52 C Tutorial(6)
Infection control & MI 8.5,8.6 NSI SST infections
MI 8.5, 8.6 BMW (Seminar 3)
Tuesday SDL 3a L54 52 B SGD 31 PA32.6 CA Pancreas Clinical Posting
22-04-2025 PA25.5
PH 1.2
Portal Hypertension C DOAP (29) PH 3.6
Evidence Based Medicine
Interaction with MR
A ((Pandemic Module 5) PM 2.1
Infection control & MI 8.5, 8.6 NSI
MI 8.5, 8.6 BMW (Seminar 3)
Wednesday L43 L47 52 C SGD 32PA36.1 Retinoblastoma
23-04-2025
MI 4.2,4.3,8.13,8.15 PH 1.36 A DOAP (28) PH 3.5
Parasitic inf. of skin, soft tissue Osteoporosis P drug test
(SST) B (Pandemic Module 5) PM 2.1
Infection control & MI 8.5, 8.6 NSI
MI 8.5, 8.6 BMW (Seminar 3)
Thursday L55 L48 [AITO Thyroid ] 54 A SGD 32PA36.1 Retinoblastoma
24-04-2025 PA25.3 (Revision)
Hepatitis
PH1.36
Thyroid disorders B DOAP (29) PH 3.6
Interaction with MR
C SGD (33) MI7.1,7.3
Enterococcus
Friday Integrated Session L44 53 B SGD 32PA36.1 Retinoblastoma
25-04-2025 PA 32.1,32.2,
32.3,23.3,32.5 MI C SGD (25)PH 5.5
PH 1.36 4.2,4.3,8.13,8.15 Caution in drug dependence
Fungal inf. of A SGD (33) MI7.1,7.3
skin, soft tissue Enterococcus

Saturday PANDEMIC Module 2.5 L45 53 C SGD 32PA36.1 Retinoblastoma Break

26-04-2025 (Revision)
Therapeutic strategies MI 3.1,3.2
including new drug Hydatid Disease A DOAP (29) PH 3.6
development Interaction with MR
(Pharmacology, General
Medicine) B SGD (33) MI7.1,7.3
Enterococcus
Week 35 07:30 - 08:30 AM 08:30 - 09:30 AM 09:30 - 11:30 AM 11:30 AM- 12:30 - 01:30 01:30 - 02:30 PM 02:30 - 03:30 PM
12:30 PM PM
Monday AETCOM 2.6 Bioethics SDL L57 55 A SGD 33PA24.3 Peptic Ulcer 54 B Retinoblastoma SPORTS 10
28-04-2025 Anchoring lecture SDL 2a
PA26.4 Tuberculosis
(Revision)
B SGD (25)PH 5.5 C SGD (24) PH 1.13
Caution in drug dependence Tutorial Adr and Antiadr
C DOAP (16) MI 1.2 A Tutorial (6)
Gram Staining-5
SST infections

Tuesday HOLIDAY Clinical Posting

29-04-2025

Break

L46[AITO-Jaundice] L49 54 C SGD 33PA24.3 Peptic Ulcer

Wednesday MI 3.1,3.7,3.8,8.13,8.15 PH 1.34
30-04-2025
Hepatitis A& E Anti/emetics A SGD (25)PH 5.5
PY 2.5, IM 5.3 Caution in drug dependence
B DOAP (16) MI 1.2
Gram Staining-5
L58 [AITO-Jaundice L50 56 A DOAP 18 PA34.1,34.4 SCC Skin
Thursday PA25.2 PH 1.34
01-05-2025 Hepatic Failure
Peptic ulcer B SGD (26) PH 5.7
Legal & ethical presc
C SGD (34) [AITO-
Jaundice]MI3.1,3.7,3.8,8.13,8.15
Viral Hepatitis
L59 [AITO-Jaundice L47[AITO-Jaundice] 55 B SGD 33PA24.3 Peptic Ulcer
Friday PA25.4
ALD, Cirrhosis Testing MI
02-05-2025 C SGD (26) PH 5.7
3.1,3.7,3.8,8.13,8.15
Hepatitis B Legal & ethical presc
PA 25.6 A SGD (34) [AITO-
Jaundice]MI3.1,3.7,3.8,8.13,8.15
Viral Hepatitis
Saturday L51 L48[AITO-Jaundice] 55 C DOAP 18 PA34.1,34.4 SCC Skin
03-05-2025 PH 1.34 MI3.1,3.7,3.8,8.13,8.15 A SGD (26) PH 5.7
Inflammatory Hep.C& Others Legal & ethical presc
Bowel Disorders IM 5.3 B SGD (34) [AITO-
Jaundice]MI3.1,3.7,3.8,8.13,8.15
Viral Hepatitis

Week 36 07:30 - 08:30 AM 08:30 - 09:30 AM 09:30 - 11:30 AM 11:30 AM- 12:30 - 01:30 01:30 - 02:30 PM 02:30 - 03:30 PM
12:30 PM PM
Monday HOLIDAY
05-05-2025

Tuesday SDL 3b L60 56 B + DOAP 18 PA34.1,34.4 SCC Skin Clinical Posting

PH 1.2 PA26.6
06-05-2025 Lung Tumours C SGD (27) PH 1.63
Evidence Based Medicine
Drug regulation Break
A SGD (35)MI 6.1
Pertussis
L49 L52 56 C DOAP 18PA34.2,34.4 BCC Skin
Wednesday PH1.32
MI 6.1,6.2,8.15
07-05-2025 A SGD (27) PH 1.63
Upper Respiratory Tract Pharmacotherapy
of Drug regulation
Infections
COPD B SGD (35)MI 6.1
Pertussis
L61 L53 57 A DOAP 18PA34.2,34.4 BCC Skin
Thursday PA28.5 PH 1.33
Glomerulonephritis
08-05-2025 Treatment of B SGD (27) PH 1.63
Cough Drug regulation
C SGD (36)MI6.1,6.2,8.15
Diphtheria & Albert Staining
L62 L50 57 B DOAP 18PA34.2,34.4 BCC Skin
Friday PA28.6,28.8
IgA Nephropathy, Tubular Diseases
MI 6.1,6.3, 1.2,
09-05-2025 C SGD (28) PH 1.2
8.15
Thera Drug Monitoring
 Lower A SGD (36)MI6.1,6.2,8.15
Diphtheria & Albert Staining
Respiratory
Tract Infections
L54 L51 57 C DOAP 18PA34.2,34.4 BCC Skin
Saturday PH 1.32 MI 6.1,6.3 A SGD (28) PH 1.2
10-05-2025 Bronchial asthma Atypical Thera Drug Monitoring
Pneumonia B SGD (36)MI6.1,6.2,8.15
Diphtheria & Albert Staining

Week 37 07:30 - 08:30 AM 08:30 - 09:30 AM 09:30 - 11:30 AM 11:30 AM- 12:30 - 01:30 01:30 - 02:30 PM 02:30 - 03:30 PM
12:30 PM PM

Monday AETCOM 2.6 Bioethics Discussion and L63 58A DOAP 19[AITOJaundice]PA25.6 LFTs
12-05-2025 closure PA28.9,28.10 FAP Field Visit VIII
ATN, Pyelonephritis
B SGD (28) PH 1.2
Thera Drug Monitoring
C SGD (37) MI6.1,6.3,4.3
Non-fermenters
Break
Tuesday SDL 4a L64 58B DOAP 19[AITOJaundice]PA25.6 LFTs Clinical Posting
13-05-2025 PA28.11
PH 1.61
Vascular Ds. of Kidney
Dietary Supplements C SGD (29) PH 1.60
Pharmacoeconomics
A SGD (37) MI6.1,6.3,4.3
Non-fermenters
Wednesday L52 L55 58 C DOAP 19[AITOJaundice]PA25.6 LFTs
14-05-2025 MI6.1,6.3,1.2,8.16 PH 1.18
Tuberculosis Intro CNS & A SGD (29) PH 1.60
General Pharmacoeconomics
anaesthetics B SGD (37) MI6.1,6.3,4.3
Non-fermenters
Thursday L65 L56 59 A DOAP 20[AITOJaundice]PA25.6
15-05-2025 PA28.12,28.15Cystic Ds. Of PH 1.19 Obs/Non-ObsJaundice
Kidney,
ThrombAngiopathie Sedatives
s and hypnotics B SGD (29) PH 1.60
Pharmacoeconomics
 C DOAP (17)MI 1.2
ZN staining-4
Friday L66 59 B DOAP 20[AITOJaundice]PA25.6
16-05-2025 PA28.14,28.16 Obs/Non-ObsJaundice
Renal &Urothelial L53
Tumours MI C SGD (30) PH 1.48
6.1,6.3,1.2,8.16 UTI/STD
NTM A DOAP (17) MI 1.2
ZN staining-4

Saturday L57 L54 59 C DOAP 20[AITOJaundice]PA25.6

17-05-2025 Obs/Non-ObsJaundice
PH 1.19 MI 6.1,6.2,6.3
Anti/depressants Myxoviruses A SGD (30) PH 1.48
UTI/STD
B DOAP (17)MI 1.2
ZN staining-4

Week 38 07:30 - 08:30 AM 08:30 - 09:30 AM 09:30 - 11:30 AM 11:30 AM- 12:30 - 01:30 01:30 - 02:30 PM 02:30 - 03:30 PM
12:30 PM PM

Monday AETCOM 2.7 Bioethics Introduction to L67 60 A SGD 37PA26.2 Lung Abcess 60 C DOAP17 34.4 Skin tumours SPORTS 11
19-05-2025 case SDL 2b microscopy
PA26.4 Tuberculosis
B SGD (30) PH 1.48 A SGD (24) PH 1.13
UTI/STD Tutorial Adr and Antiadr
C SGD (38) MI 6.1,6.2 60 B Tutorial(6)
Misc. Viral Respiratory Infections
SST infections
Break

Tuesday Integrated Session (Jaundice) L68 60 B SGD 37PA26.2 Lung Abcess Clinical Posting
20-05-2025 MI 3.1,3.7,3.8,8.13,8.15 SDL 3a Clinical Posting
PY 2.5 PA28.2 Renal Failure C SGD (31) PH 1.53
IM 5.3 Chelating agents
PA 25.2,25.4,25.6
A SGD (38) MI 6.1, 6.2
Misc. Viral Respiratory Infections
Wednesday L55 L58 61 C SGD 37PA26.2 Lung Abcess
21-05-2025
MI 6.1,6.2,6.3 PH 1.19
A SGD (31) PH 1.53
Coronavirus Infections
Chelating agents
 Antipsychotic B SGD (38) MI 6.1, 6.2
drugs Misc. Viral Respiratory Infections

L69 L59 61 A SGD 38PA26.7 Mesothelioma

Thursday PA29.1 PH 1.19
22-05-2025 Testicular Tumours B SGD (31) PH 1.53 Break
Opioids
Chelating agents
C SGD (39) MI6.1,6.2,6.3
Parasitic inf. of Respiratory tract

Friday L70 L56 61 B SGD 38PA26.7 Mesothelioma

23-05-2025 PA29.5,29.3,29.4
Prostatitis, BPH, Ca
MI
6.1,6.2,6.3 C SGD (32) PH 1.18
Prostate
Pre anaesthetic med
Fungal
A SGD (39) MI6.1,6.2,6.3
Respiratory Parasitic inf. of Respiratory tract
Infections

Saturday L60 L57 62 C SGD 38PA26.7 Mesothelioma

24-05-2025
PH 1.19 MI 7.1,7.3 A SGD (32) PH 1.18
Anti/epileptics Bacterial Pre anaesthetic med
UTIs B SGD (39) MI6.1,6.2,6.3
Parasitic inf. of Respiratory tract

Week 39 07:30 - 08:30 AM 08:30 - 09:30 AM 09:30 - 11:30 AM 11:30 AM- 12:30 - 01:30 PM 01:30 - 02:30 PM 02:30 - 03:30 PM
12:30 PM

Monday AETCOM 2.7 Bioethics SDL L71 62 A SGD 39PA29.2 CA Penis 63 A DOAP17 34.4 Skin tumours SPORTS 12
26-05-2025 PA30.6,30.1
Cervicitis, Ca Cervix
microscopy
B SGD (33) PH 1.14
Tutorial Chol and AntiChol
B SGD (32) PH 1.18 Clinical Posting
 Pre anaesthetic med
Break
C SGD (40) MI7.1,7.3
Parasitic & Fungal inf. of urogenital
tract

SDL 5a L72 62 B SGD 39PA29.2 CA Penis

Tuesday PH 1.22 SDL 3b
27-05-2025 PA28.2 Renal Failure
Drug abuse and deaddiction
C DOAP (30) PH 1.3
Oral Dosage Forms
(Revision)
A SGD (40) MI7.1,7.3
Parasitic & Fungal inf. of
urogenital tract
Wednesday L58 L61 63 C SGD 39PA29.2 CA Penis
28-05-2025
MI 7.1,7.2,8.15 PH 1.19 A DOAP (30) PH 1.3
Syphilis-I Anti/parkinsonian Oral Dosage Forms (Revision)
drugs B SGD (40) MI7.1,7.3
Parasitic & Fungal inf. of urogenital
tract
Thursday L73 L62 64 A SGD 40,41PA30.5 Gestational
29-05-2025 PA30.4 Tumour
PH 1.19
Ovarian Tumours
Alzheimer’s disease B DOAP (30) PH 1.3
Oral Dosage Forms (Revision)
C DOAP (18) MI 8.5, 8.6
Hand Hygiene& PPE-3
Friday L74 L59 63 B SGD 40,41PA30.5 Gestational
30-05-2025 PA30.4 Tumour
Ovarian Tumours
MI 7.1,7.2,8.15
Syphilis-II C SGD (34) PH 1.19
Anti-manic drugs
A DOAP (18) MI 8.5, 8.6
Hand Hygiene& PPE-3
Saturday L63 L60 64 C SGD 40,41PA30.5 Gestational
31-05-2025 Tumour
PH 1.42 MI 7.1,7.2,8.15
General Chemotherapy Gonorrhoea A SGD (34) PH 1.19
Anti-manic drugs
B DOAP (18) MI 8.5, 8.6
Hand Hygiene& PPE-3
Week 40 07:30 - 08:30 AM 08:30 - 09:30 AM 09:30 - 11:30 AM 11:30 AM- 12:30 - 01:30 PM 01:30 - 02:30 - 03:30 PM
12:30 PM 02:30 PM

Monday AETCOM 2.8 What does it mean to L75 65 A SGD41 28.1 Normal Kidney FAP Field Visit IX
02-06-2025 be family of sick patient Hospital PA30.7,30.2,30.3,30.9
visit and interviews Endometriosis, Endo
Histology
Hyperplasia, Ca Endo, B SGD (34) PH 1.19
Leiomyomas,
Leiomyosarcomas Anti-manic drugs
SPORTS 13
PA31.2 C SGD (41)MI7.1,7.2,8.15 Break 65 B DOAP17 34.4 Skin tumours
Ca Breast Other Genital Diseases microscopy

Tuesday SDL 5b L76 64 B SGD41 28.1 Normal Kidney C SGD (33) PH 1.14
03-06-2025 PA30.7,30.2,30.3,30.9
PH 1.22 Histology Tutorial Chol and AntiChol
Endometriosis, Endo
Drug abuse and deaddiction Hyperplasia, Ca Endo, C DOAP (31) PH 2.1/4.1
Leiomyomas, Parenteral & Inhalational
Leiomyosarcomas
Route (Revision)
A SGD (41) MI7.1,7.2,8.15 66 C DOAP20 23.3 Renal Function SPORTS 14
Other Genital Diseases Tests
Wednesday L61 L64 65 C SGD41 28.1 Normal Kidney
04-06-2025
MI 7.1,7.2,8.15 PH 1.42 Histology
Non-gonococcal Urethritis Protein Synthesis A DOAP (31) PH 2.1/4.1 A SGD (33) PH 1.14
Inhibitors Parenteral & Inhalational Tutorial Chol and AntiChol
(Tetracyclines) Route (Revision)
B SGD (41) MI7.1,7.2,8.15
Other Genital Diseases
L77 L65 66 A DOAP20 23.3 Renal 67 A SGD 42 PA28.3 Acute Renal Failure SPORTS 15
SDL 4a PH 1.42 Function Tests
Thursday PA30.8 Adenomyosis
Protein Synthesis B DOAP (31) PH 2.1/4.1
05-06-2025
Inhibitors Parenteral & Inhalational
(Aminoglycosides) Route (Revision)
 C Tutorial (7) B SGD (35) PH 1.58
All STI’s Ocular disorders 1
L78 L62 66 B DOAP20 23.3 Renal
SDL 4b Function Tests
PA30.8 Adenomyosis
MI
Friday
5.1,5.2,5.3,1.2,8.15 C DOAP (32) PH 1.9 67 B SGD 42 PA28.3 Acute Renal Failure
06-06-2025
Bacterial IV Drip (Revision) SPORTS 16
Meningitis A Tutorial (7) C SGD (35) PH 1.58
All STI’s Ocular disorders 1

Saturday HOLIDAY
07-06-2025

Week 41 07:30 - 08:30 AM 08:30 - 09:30 AM 09:30 - 11:30 AM 11:30 AM- 12:30 - 01:30 PM 01:30 02:30 - 03:30 PM
12:30 PM -
02:30
PM

Monday AETCOM 2.8 What does it mean to L79 68 A SGD43 28.4 Chronic Renal 69 A SGD 45PA28.13 Renal Stones SPORTS17
09-06-2025 be family of sick patient Hospital PA33.1
visit and interviews Failure
Osteomyelitis
B DOAP (32) PH 1.9 B SGD (36) PH 1.58
IV Drip (Revision) Ocular disorders 2
C SGD (42)MI5.2,8.15
Slow Virus Diseases
Tuesday SDL 6a L80 68 B SGD43 28.4 Chronic Renal Break 69 B SGD 45PA28.13 Renal Stones SPORTS18
10-06-2025 PA35.2
PH 1.51 Failure
CNS Tumours
Pesticides, Insect Repellants, C DOAP (33) PH 2.2
Pollutants and Food ORS (Revision)
Adulterants A SGD (42) MI5.2,8.15 C SGD (36) PH 1.58
Slow Virus Diseases Ocular disorders 2
HOLIDAY
Wednesday
11-06-2025
 L81 L66 70 A SGD 44 28.7 Glomerular 71 A DOAP8 23.3 Semen analysis SPORTS 19
Thursday PA35.2 PH1.42 manifestations in systemic
12-06-2025 CNS Tumours
Beta lactam diseases
antibiotics 1 B DOAP (33) PH 2.2 B SGD (37) PH 1.54
ORS (Revision) Vaccines 1
C DOAP (19)MI 1.2
Gram staining-6

L82 70 B SGD 44 28.7 Glomerular 71 B DOAP8 23.3 Semen analysis SPORTS 20

SDL 5a manifestations in systemic
PA35.1 CSF Findings in L63
Friday diseases
13-06-2025
Meningitis MI 5.1,5.3,8.16
Viral Meningitis C DOAP (34) PH 4.2 C SGD (37) PH 1.54
Drugs on rabbit’s eye Vaccines 1
(Simulation) (Revison)
A DOAP (19) MI 1.2
Gram staining-6
L67 L64 67 C SGD 42 PA28.3 Acute Renal 68 C SGD 45PA28.13 Renal Stones SPORTS 21
PH1.42 MI 5.2,8.15 Failure +
Saturday Beta lactam antibiotics 2 SGD43 28.4 Chronic Renal Failure
14-06-2025
Viral
Encephalitis-I A DOAP (32) PH 1.9 A SGD (35) PH 1.58
IV Drip (Revision) Ocular disorders 1
B DOAP (19) MI 1.2
Gram staining-6
Tutorial(7) : All STI’s

Week 42 07:30 - 08:30 AM 08:30 - 09:30 AM 09:30 - 11:30 AM 11:30 AM- 12:30 - 01:30 PM 01:30 - 02:30 - 03:30 PM
12:30 PM 02:30
PM
Monday HOLIDAY
16-06-2025

SDL 6b L83 72 B SGD 43PA28.4 Chronic Renal 73 B DOAP8 23.3 Semen SPORTS 22
Tuesday PA33.2,33.3 Failure
PH 1.51 analysis (Revision)
17-06-2025 Bone & Soft Tissue Tumours Break
Pesticides, Insect Repellants, C SGD (39) PH 1.43
Pollutants and Food Antibiotic Stewardship
Adulterants A SGD (43)MI 1.1,8.15 C SGD (38) PH 1.54
Ocular & Ear Infs.
Vaccines 2
SDL 5a L68 69 C SGD 44 28.7 Glomerular
Wednesday PH 1.42 manifestations in systemic
18-06-2025
MI 7.1,7.2,7.3,8.15
STDs Protein Synthesis diseases
Inhibitors A DOAP (33) PH 2.2 70 C DOAP8 23.3 Semen SPORTS 23
(Macrolides) ORS (Revision) analysis
B SGD (43)MI 1.1,8.15 A SGD (36) PH 1.58
Ocular & Ear Infs. Ocular disorders 2
Thursday L84 L69 72 A SGD46 31.1 Benign Breast 73 A SGD47 31.4 SPORTS 24
19-06-2025 PA33.2,33.3
Bone & Soft Tissue Tumours
PH 1.42 Disease Gynecomastia
Sulphonamides and B DOAP (34) PH 4.2 B SGD (38) PH 1.54
quinolones Drugs on rabbit’s Vaccines 2
eye (Simulation)
(Revison)
C SGD (44)MI8.4 75 B Gynecomastia SPORTS 25
Emerging & Re-emerging Infs.
Friday L85 L65 74 B SGD46 31.1 Benign Breast
20-06-2025 PA33.5
MI 5.2,8.15 Disease
Rh. Arthritis
Viral Encephalitis- C DOAP (35) PH 4.2 C SGD (40)
II Drugs on Dog’s Vitamins and
BP (Simulation) Minerals
(Revison)
A SGD (44)MI8.4
Emerging & Re-emerging Infs.
L70 L66 71 C SGD46 31.1 Benign Breast 72 C Gynecomastia SPORTS 26
PH 1.44 MI 4.1 Disease
Saturday
Anti/ tubercular drugs Tetanus A SGD (39) PH 1.43
21-06-2025
Antibiotic Stewardship
 B SGD (44)MI8.4 A SGD (37) PH 1.54
Emerging & Re-emerging Infs. Vaccines 1

Week 43 07:30 - 08:30 AM 08:30 - 09:30 AM 09:30 - 11:30 AM 11:30 AM- 12:30 - 01:30 PM 01:30 02:30 - 03:30 PM
12:30 PM -
02:30
PM

Monday AETCOM 2.8 What does it mean to L86 74 A DOAP21 31.3 Carcinoma 75 A DOAP22 35.3 CSF SPORTS27
23-06-2025 be family of sick patient Large SDL 5b
group discussion
Breast Parameters
PA35.1 CSF Findings in
Meningitis B SGD (39) PH 1.43 B SGD (40)
Antibiotic Stewardship Vitamins and
Minerals
Tuesday L71 L87 76 B Carcinoma
DOAP21 31.3 Break 77 B DOAP22 35.3 CSF Parameters SPORTS 28
24-06-2025 REVISION
PH 1.45 Breast
MDR & XDR TB C DOAP (36) PH 4.2 C SGD (43) PH 1.60
Unknown Drugs on Dog’s BP Pharmacogenomics
(Simulation) (Revison)

SDL 5b L72 73 C Carcinoma

DOAP21 31.3 74 C DOAP22 35.3 CSF Parameters SPORTS 29
Wednesday MI7.1,7.2,7.3,8.15 PH 1.46 Breast
25-06-2025
STDs Anti/leprotic drugs A DOAP (34) PH 4.2 A SGD (38) PH 1.54
Drugs on rabbit’s eye Vaccines 2
(Simulation) (Revison)

L88 L73 76 A SGD34 34.3 Melanoma 77 A DOAP22 35.3 CSF SPORTS 30

Thursday REVISION PH 1.48 Parameters
26-06-2025
Anti/viral drugs B DOAP (35) PH 4.2 B SGD (43) PH 1.60
Drugs on Dog’s BP Pharmacogenomics
(Simulation) (Revison)
 L89 L67 78 B SGD34 34.3 Melanoma 79 B DOAP22 35.3 CSF Parameters SPORTS 31
REVISION MI
Friday 5.1,5.2,5.3,8.15 C DOAP (37) PH 4.2 C SGD (43) PH 1.57
27-06-2025 Experimental Graphs Skin disorders 1
Fungal CNS
(Simulation) (Revison)
infections

L74 L68 75 C SGD34 34.3 Melanoma 76 C DOAP22 35.3 CSF Parameters SPORTS 32
PH 1.47 MI5.1,5.2,5.3,8.15
Saturday Anti/fungal drugs Parasitic CNS A DOAP (35) PH 4.2 A SGD (40)
28-06-2025 Drugs on Dog’s BP Vitamins and
infections
(Simulation) (Revison) Minerals

Week 44 07:30 - 08:30 AM 08:30 - 09:30 AM 09:30 - 11:30 AM 11:30 12:30 - 01:30 01:30 - 02:30 PM 02:30 - 03:30 PM
AM- PM
12:30
PM
Monday AETCOM 2.8 What does it L90 78 A INSTRUMENTS FAP Field Visit X
30-06-2025 mean to be family of sick REVISION
patient SDL B DOAP (36) PH 4.2
Unknown Drugs on Dog’s BP
(Simulation) (Revison)

Break
Tuesday SDL 4b L75 80 B INSTRUMENTS 81 B REVISION SPORTS 33
01-07-2025 PH 1.61 PH 1.48
Dietary Supplements Anti/retroviral drugs C SGD (41)PH 1.55 C SGD (44) PH 1.57
Quiz National Programs Skin disorders 2

Wednesday L69 L76 77 C INSTRUMENTS 78 C REVISION SPORTS 34

02-07-2025 MI 1.1,8.15 PH 1.49 A DOAP (36) PH 4.2 A SGD (43) PH 1.60
Congenital Infections Anti/cancer drugs - 1 Unknown Drugs on Dog’s BP Pharmacogenomics
(Simulation) (Revison)

Thursday L77 79 A GROSS SPECIMENS 80 A REVISION SPORTS 35

03-07-2025 PH 1.49 AND SPOTS
Anti/cancer drugs - 2 B DOAP (37) PH 4.2 B SGD (43) PH 1.57
Experimental Graphs Skin disorders
(Simulation) (Revison)

Friday L70 82 B GROSS SPECIMENS 83 B REVISION

04-07-2025 MI 8.3 & SPOTS
Oncogenic Viruses C SGD (42)PH 1.55 C SGD (45) PH1.50
Quiz National Immunomodulators
Programs

Saturday L78 L71 79 C GROSS SPECIMENS 80 C REVISION

05-07-2025 PH 1.47 MI 8.1 AND SPOTS
Anti/amoebic drugs Zoonotic A DOAP (37) PH 4.2 A SGD (43) PH 1.57
Infections Experimental Skin disorders 1
Graphs
(Simulation)
(Revison)

Week 45 07:30 - 08:30 AM 08:30 - 09:30 AM 09:30 - 11:30 AM 11:30 AM- 12:30 - 01:30 01:30 - 02:30 PM 02:30 - 03:30
12:30 PM PM PM

Monday AETCOM Reflective 81 A REVISION

07-07-2025 writing and
submission of manual 82 A Revision

B SGD (41)PH 1.55 B SGD (45) PH1.50

Quiz National Programs Immunomodulators
C SGD (45) MI 8.1
Vector borne infections
Tuesday 84 B REVISION
08-07-2025
C SGD (46) PH 1.57 Break
Anti/septic and
disinfectants
A SGD (45) MI 8.1
Vector borne infections
Wednesday 81 C REVISION
09-07-2025 L79
PH 1.47 82 C REVISION
Anti –
helminthic drugs A SGD (41)PH 1.55 A SGD (44) PH 1.57
Quiz National Programs Skin disorders 2
B SGD (45) MI 8.1
Vector borne infections
84 A REVISION

Thursday L80 83 A REVISION

10-07-2025 PH 1.47 B SGD (42)PH 1.55 B SGD (46) PH 1.57
Anti/malarial Quiz Anti/septic and disinfectants
drugs National
Programs
CDOAP (20)MI 1.2
ZN staining-5
Friday 85 B
11-07-2025 REVISION
C File Checking A SGD (46) PH 1.57
Anti/septic and disinfectants
ADOAP (20)MI 1.2
ZN staining-5
Saturday 83 C
12-07-2025 REVISION
84 C revision

A SGD (42)PH 1.55 A SGD (45) PH1.50

Quiz National Programs Immunomodulators
B DOAP (20)MI 1.2
ZN staining-5

PATHOLOGY SGD count: A – 82, B – 85, C – 82.

MICROBIOLOGY SGD Count: A – 71, B - 70, C - 68.
PHARMACOLOGY SGD count: A - 80, B -81, C – 85.

Week 46 07:30 - 08:30 AM 08:30 - 09:30 AM 09:30 - 11:30 AM 11:30 AM- 12:30 - 01:30 PM 01:30 - 02:30 PM 02:30 - 03:30 PM
12:30 PM

Summer
Holidays
14-07-2025 to
20-07-2025
Monday PRE-UNIVERSITY EXAMINATION
21-07-2025
onward